Novel triterpenoids from Alisma plantago-aquatica with influence on LDL uptake in HepG2 cells by inhibiting PCSK9

“Force iteration molecular designing” strategy for the systematic characterization and discovery of new protostane triterpenoids from Alisma Rhizoma by UHPLC/LTQ-Orbitrap-MS

(2021) Jianqing Zhang et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Heart to heart with PCSK9

(2021) Kevin Chemello et al.   EUROPEAN HEART JOURNAL

Gypenoside LVI improves hepatic LDL uptake by decreasing PCSK9 and upregulating LDLR expression

(2021) Jie Wang et al.   PHYTOMEDICINE

Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall

(2020) Yanan Guo et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Novel C-17 spirost protostane-type triterpenoids from Alisma plantago-aquatica with anti-inflammatory activity in Caco-2 cells

(2019) Qinghao Jin et al.   Acta Pharmaceutica Sinica B

Indole Alkaloid from Nauclea latifolia promotes LDL uptake in HepG2 cells by inhibiting PCSK9

(2018) Mike Okweesi Aggrey et al.   PHYTOMEDICINE

Novel protostane-type triterpenoids with inhibitory human carboxylesterase 2 activities

(2017) Zhi-Jie Zhang et al.   RSC Advances

Stress-induced upregulation of VLDL receptor alters Wnt-signaling in neurons

(2016) Kai Kysenius et al.   EXPERIMENTAL CELL RESEARCH

A review of PCSK9 inhibition and its effects beyond LDL receptors

(2016) Dave L. Dixon et al.   Journal of Clinical Lipidology

Chemical constituents of Alisma orientalis

(2014) Yin Qiang et al.   CHEMISTRY OF NATURAL COMPOUNDS

Traditional uses, phytochemistry, pharmacology, toxicology and quality control of Alisma orientale (Sam.) Juzep: A review

(2014) Ting Tian et al.   JOURNAL OF ETHNOPHARMACOLOGY

A new triterpenoid from Alisma orientalis

(2008) Xue Yan Hu et al.   CHINESE CHEMICAL LETTERS

Alisolide, alisols O and P from the rhizome of Alisma orientale

(2007) Ming Zhao et al.   PHYTOCHEMISTRY